Jane F. Apperley

发表

Enhanced retroviral gene transfer into CML and normal bone marrow, and CML and mobilized peripheral blood CD34+ cells using the recombinant fibronectin fragment CH‐296

J. Melo, J. Goldman, A. Miller, 1999, British journal of haematology.

Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib

D. Marin, J. Goldman, M. Bua, 2005, Cancer.

Unrelated donor peripheral blood stem cell transplants incorporating pre‐transplant in‐vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft‐versus‐host disease

C. Craddock, N. Russell, J. Byrne, 2011, British journal of haematology.

Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib‐responsive myeloproliferative neoplasms

A. Chase, F. Grand, N. Cross, 2010, British journal of haematology.

Plasmacytoma relapses in the absence of systemic progression post‐high‐dose therapy for multiple myeloma

K. Rezvani, S. Basu, E. Terpos, 2005, European Journal of Haematology.

The post‐transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase

D. Blaise, R. Clark, G. Meloni, 2002, British journal of haematology.

Expression of interleukin‐1β and tumour necrosis factor‐α in plasma cells from patients with multiple myeloma

P. Croucher, M. Greaves, R. Russell, 1999 .

Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation.

C. Craddock, P. Moss, J. Ainsworth, 2001, Blood.